Biotechnology
Germany
Unitedstates
Cancer
Therapy
Development
Novel
M&A Advisory
Lazard
Full Credential Description
Agennix. Germany, United States. Announced Date 18/02/2009. Closed Date 05/11/2009. GPC Biotech and Agennix announce proposed merger. Industry: Agennix is a biotechnology company focused on the development of novel therapies for cancer and other serious diseases.